Ive been working as an addiction specialist and started to get feedback both from patients and colleagues that for some reason individuals treated with GLP-1 agonists (especially semaglutide) seem to lose interest in using alcohol (some even develop an aversion), said study author Markku Lhteenvuo, a docent in forensic psychiatry at the University of Eastern Finland and the Niuvanniemi Hospital
JAMA Cardiol 2021;6:148-58.ArticlePubMed 46
How brands are changing their products are observed by the latest GLP-1 food and beverage trends for 2026
Description Are you ready to unlock the secret to radiant, youthful skin and bolster your overall well-being
In a separate editorial, Holden Thorp, the publications editor-in-chief, noted that these drugs have raised more questions than they have answereda hallmark of a true breakthrough.[1] More research is needed into the potential side effects of the long-term use of these drugs, for example, and fears are growing that patients will abuse GLP-1 agonists, taking them when they arent clinically necessary
